Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
11.77
+0.79 (7.19%)
May 29, 2026, 12:10 PM EDT - Market open
Personalis Market Cap
Personalis has a market cap or net worth of $1.23 billion as of May 29, 2026. Its market cap has increased by 171.50% in one year.
Market Cap
1.23B
Enterprise Value
955.40M
1-Year Change
171.50%
Ranking
Category
Stock Price
$11.77
Market Cap Chart
Since June 20, 2019, Personalis's market cap has increased from $847.61M to $1.23B, an increase of 45.42%. That is a compound annual growth rate of 5.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 1.15B | 62.66% |
| Dec 31, 2025 | 706.88M | 72.20% |
| Dec 31, 2024 | 410.49M | 298.67% |
| Dec 29, 2023 | 102.97M | 13.12% |
| Dec 30, 2022 | 91.02M | -85.76% |
| Dec 31, 2021 | 639.07M | -55.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veracyte | 3.56B |
| GRAIL | 3.07B |
| Adaptive Biotechnologies | 2.22B |
| GeneDx Holdings | 1.43B |
| NeoGenomics | 1.25B |
| CareDx | 1.14B |
| OPKO Health | 989.17M |
| Castle Biosciences | 645.72M |